Accessibility Menu
NanoLogix logo

NanoLogix(OTC) NNLX

Current Price$0.00
Market Cap$9.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-100%
5 Year-100%
1 Year-20%
1 Month-20%
NanoLogix last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-10
NanoLogix stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-20%USD 0.002026-06-09
1 month-20%USD 0.002026-06-09
3 month-20%USD 0.002026-03-16
Year to date+7,900%USD 0.002025-12-31
1 year-20%USD 0.002025-06-26
3 year-20%USD 0.002023-07-07
5 year-99.69%USD 0.032021-07-09
Since inception-99.92%USD 0.102003-06-18

NanoLogix Financials at a Glance

Market Cap

$9.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

11.72 (High)

Price

$0.00

Volume

12,235

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

N/A

NNLX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NanoLogix

NanoLogix, Inc. is a biotechnology firm focused on developing rapid diagnostic and live cell test kits. The company specializes in accurately detecting viable bacteria and various microorganisms, serving multiple sectors including medical diagnostics and environmental monitoring.

Products and Services
  • BioNanoPore kit for detecting microorganisms
  • FlatPack Petri Plate for isolating diverse microorganisms
  • Diagnostic solutions for medical and industrial applications
Growth Outlook
  • Established clientele includes prominent medical and scientific organizations
  • Broad application across healthcare, defense, and environmental sectors
  • Potential for expansion in pharmaceutical research and manufacturing
Financial Highlights
  • Market capitalization stands at approximately $11,961
  • Current ratio of 1.08 indicates adequate short-term liquidity
  • Price-to-sales ratio of 0.34 suggests potential undervaluation
NanoLogix, Inc. operates from Hubbard, Ohio, and has a dedicated focus on innovative solutions in the biotechnology sector. The company's products are designed to meet the needs of various industries, ensuring accurate and rapid diagnostics. With a strong foundation in research and development, NanoLogix is positioned to capitalize on growth opportunities in the expanding biotechnology market. The financial metrics indicate a company with potential for future growth, particularly in light of its established relationships and diverse applications.
AI Generated • Jul 11, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Hubbard, OH 44425, US

NNLX Financials

Key Financial Metrics (TTM)

Gross Margin

-1994.62%

Operating Margin

-3646.21%

Net Income Margin

-3631.21%

Return on Equity

-172.49%

Return on Capital

-182.60%

Return on Assets

-177.90%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

119.61M

Volume

12.23K

Avg. Volume

821.065

Financials (TTM)

Gross Profit

-$710.04K

Operating Income

-$1.30M

EBITDA

-$1.18M

Operating Cash Flow

-$697.45K

Capital Expenditure

-$4.00

Free Cash Flow

-$697.45K

Cash & ST Invst.

$3.34K

Total Debt

$100.18K

NanoLogix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$9.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TRVNTrevena, Inc.
$0.01+0.00%
INFIQInfinity Pharmaceuticals, Inc.
$0.00+0.00%
HLUNHEALTHeUNIVERSE, Inc.
$0.00+0.00%
VAXXVaxxinity, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About NNLX

What is the current price of NanoLogix?

NanoLogix is trading at $0.00 per share.

What is the 52-week range for NanoLogix?

Over the past 52 weeks, NanoLogix has traded between $0.00 and $0.04.

How much debt does NanoLogix have?

NanoLogix total debt is unavailable.

How much cash does NanoLogix have on hand?

NanoLogix does not have cash on hand data available.

What is NanoLogix’s dividend yield?

NanoLogix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services